The first malaria vaccine was administered to a little girl in Cameroon.
Cameroon has become the first country in the world to launch a specific program for the malaria vaccine.
It is predicted that this initiative will save thousands of children across Africa from the risk of death.
After successful trials in Kenya, Ghana, and Malawi, today the first vaccine was given to a little girl named Daniela in Cameroon.
The World Health Organization, by approving this vaccine produced by the British pharmaceutical company GSK, described this as a historic moment in the fight against this disease.
According to a statement from the Global Vaccine Alliance, GSK, twenty other countries plan to start this vaccination program this year.
The research and production of this vaccine have taken thirty years.
